New imaging reveals a built-in safeguard that allows B cell populations to rapidly expand in germinal centers without introducing deleterious mutations.

RNA vaccines were first developed years ago to target cancers and now they're really starting to show promise.

MUNIS enhances vaccine design for diseases like HIV and influenza. Inspired by our Teach Me in 10 video series, this inaugural online event will explore the latest in vaccine research through a ...

Vaccines against both viruses, however, have been difficult to design. Now, Scripps Research scientists have analyzed the structure and stability of a critical RSV and hMPV protein to better ...

The team’s vaccine represents a recent shift to more targeted cancer therapies than general treatments like surgery, radiation and chemotherapy that tend to prolong life in advanced cancer patients ...

Through unprecedented global collaboration, innovative technology, adaptive clinical trials, sensible regulatory revisions, and extraordinary funding, a polished vaccine R&D program came into ...